[go: up one dir, main page]

MX2007002451A - Uso de inhibidores de la conversion de hormona tiroidea. - Google Patents

Uso de inhibidores de la conversion de hormona tiroidea.

Info

Publication number
MX2007002451A
MX2007002451A MX2007002451A MX2007002451A MX2007002451A MX 2007002451 A MX2007002451 A MX 2007002451A MX 2007002451 A MX2007002451 A MX 2007002451A MX 2007002451 A MX2007002451 A MX 2007002451A MX 2007002451 A MX2007002451 A MX 2007002451A
Authority
MX
Mexico
Prior art keywords
thyroid hormone
conversion inhibitors
hormone conversion
inhibitors
relates
Prior art date
Application number
MX2007002451A
Other languages
English (en)
Inventor
Joshua D Safer
Michael F Holick
Original Assignee
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Boston filed Critical Univ Boston
Publication of MX2007002451A publication Critical patent/MX2007002451A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere al uso de inhibidores de la conversion de hormonas tiroidea para tratar trastornos cutaneos hiperproliferativos, preferentemente su uso en mezclas topicas.
MX2007002451A 2004-09-01 2005-08-30 Uso de inhibidores de la conversion de hormona tiroidea. MX2007002451A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60648104P 2004-09-01 2004-09-01
PCT/US2005/030919 WO2006028835A2 (en) 2004-09-01 2005-08-30 Use of thyroid hormone conversion inhibitors

Publications (1)

Publication Number Publication Date
MX2007002451A true MX2007002451A (es) 2007-05-11

Family

ID=36036840

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002451A MX2007002451A (es) 2004-09-01 2005-08-30 Uso de inhibidores de la conversion de hormona tiroidea.

Country Status (13)

Country Link
US (1) US20090082451A1 (es)
EP (1) EP1789032A4 (es)
JP (1) JP2008511660A (es)
KR (1) KR20070083612A (es)
CN (1) CN101090740A (es)
AU (1) AU2005282789A1 (es)
BR (1) BRPI0514815A (es)
CA (1) CA2578999A1 (es)
IL (1) IL181593A0 (es)
MX (1) MX2007002451A (es)
RU (1) RU2007111760A (es)
WO (1) WO2006028835A2 (es)
ZA (1) ZA200701800B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009015366A2 (en) * 2007-07-26 2009-01-29 Trustees Of Boston University Use of thyroid hormone conversion inhibitors to treat hyperproliferative disorders
US20130190317A1 (en) * 2010-08-06 2013-07-25 Galderma Research & Development Snc Combination of compounds for treating or preventing skin diseases
US10435365B2 (en) 2014-03-16 2019-10-08 Hadasit Medical Research Services And Development Ltd. Type III deiodinase inhibitors and uses thereof
IT202100014333A1 (it) * 2021-06-01 2022-12-01 Materias S R L Nuovo impiego terapeutico di inibitori della iodiotironina deiodinasi di tipo 2 (D2)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966967A (en) * 1973-03-21 1976-06-29 The Regents Of The University Of California Compositions and methods of treating psoriasis with vinyligs of desmethyl retinoic acid
US4021573A (en) * 1974-04-22 1977-05-03 The Regents Of The University Of California Psoriasis treatment with retinoic acid analogs
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
JPS6044250B2 (ja) * 1981-10-02 1985-10-02 日本鉱業株式会社 亜砒酸の製造方法
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
TW218849B (es) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5498636A (en) * 1992-03-13 1996-03-12 Ribogene, Inc. Treatment of angina pectoris
US5310742A (en) * 1992-11-30 1994-05-10 Elias Alan N Uses for thioureylenes
US6599448B1 (en) * 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions
GB0015205D0 (en) * 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
AU2002237298B2 (en) * 2001-02-08 2006-08-03 Karo Bio Ab Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
TW532210U (en) * 2002-02-20 2003-05-11 Chen-Wen Wang Locking device for a detachable skate of sports shoe
WO2003092617A2 (en) * 2002-05-03 2003-11-13 Combinatorx, Incorporated Combinations for the treatment of inflammatory skin disorders
WO2003094845A2 (en) * 2002-05-08 2003-11-20 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands

Also Published As

Publication number Publication date
KR20070083612A (ko) 2007-08-24
CN101090740A (zh) 2007-12-19
WO2006028835A3 (en) 2007-08-30
IL181593A0 (en) 2008-06-05
CA2578999A1 (en) 2006-03-16
RU2007111760A (ru) 2008-10-10
EP1789032A4 (en) 2008-07-30
ZA200701800B (en) 2008-09-25
JP2008511660A (ja) 2008-04-17
WO2006028835A2 (en) 2006-03-16
AU2005282789A1 (en) 2006-03-16
US20090082451A1 (en) 2009-03-26
BRPI0514815A (pt) 2008-06-24
EP1789032A2 (en) 2007-05-30

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
MX2007014132A (es) Compuestos de diarilhidantoina.
MX2008002012A (es) Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.
UA94221C2 (en) Lipocalin protein
ECSP055851A (es) Derivados de indolil pirazinona utiles para el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
CR7728A (es) Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
IS8013A (is) Mótefnasameindir með sérvirkni gagnvart IL- 1ß í mönnum
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
SE0301653D0 (sv) Novel compounds
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CL2008002775A1 (es) Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
MY158428A (en) Topical composition for the treatment of actinic keratosis
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
DOP2006000082A (es) Forma cristalina ortorrómbicadel maleato de asenapina y su uso enel tratamiento de trastornos mentales.
UY31758A (es) Forma cristalina anhidra de maleato de orvepitant
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
WO2006127525A3 (en) Proteasome inhibitors and uses thereof
UY31508A1 (es) Triazolotriazinas y triazolopirazinas y su uso
HN2006029142A (es) Proceso
MX2007002451A (es) Uso de inhibidores de la conversion de hormona tiroidea.
EA201000864A1 (ru) Фенилоксетанильные производные
ECSP109874A (es) Nuevos compuestos 892
EA200800342A1 (ru) ИНГИБИТОРЫ Glepp-1 ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И/ИЛИ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ
CR9578A (es) Inhibidores de la adenilato ciclasa soluble

Legal Events

Date Code Title Description
FA Abandonment or withdrawal